NY2267
NY2267 is a disruptor of Myc-Max interaction, with an IC50 of 36.5 μM. NY2267 inhibits Myc- and Jun-induced transcriptional activation[1].
Product Specifications
CAS Number
886053-73-2
UNSPSC
12352005
Target
C-Myc
Type
Reference compound
Related Pathways
Apoptosis
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ny2267.html
Purity
98.53
Solubility
DMSO : 250 mg/mL (ultrasonic; warming)
Smiles
O=C(OC(C)(C)C)COC1=CC=C2C=C(C(N(CC3=CC=C(OC)C=C3)C(C4=NC=CC=C4)=O)C(NC5CCCCC5)=O)C=CC2=C1
Molecular Formula
C38H43N3O6
Molecular Weight
637.76
References & Citations
[1]Yang Xu, et al. A credit-card library approach for disrupting protein-protein interactions. Bioorg Med Chem. 2006 Apr 15;14 (8) :2660-73.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-C432499-5MG 5 mg
Sodium Cholesterol-25,26,26,26,27,27,27-d7 Sulfate
Sign In for Pricing
View Details 
LY428233 100 µg
HNRPLL (HNRNPLL) (NM_001142650) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC401429-500 1x 500 µL
E-Cadherin / CD324 (Intercellular Junction Marker) (4A2), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details